Cites,Authors,Title,Year,Source,Publisher,ArticleURL,CitesURL,GSRank,QueryDate,Type,DOI,ISSN,CitationURL,Volume,Issue,StartPage,EndPage,ECC,CitesPerYear,CitesPerAuthor,AuthorCount,Age
895,"W Ye, K Shimamura, JLR Rubenstein, MA Hynes…","FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate",1998,"Cell","Elsevier","https://www.sciencedirect.com/science/article/pii/S0092867400814373","https://scholar.google.com/scholar?cites=10268526124093149333&as_sdt=800005&sciodt=0,15&hl=en",1,"2019-06-10","HTML","","","",,,,,895,42.62,179,5,21
366,"LH Parker, M Schmidt, SW Jin, AM Gray, D Beis…","The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation",2004,"Nature","nature.com","https://www.nature.com/articles/nature02416","https://scholar.google.com/scholar?cites=15380923229848884&as_sdt=800005&sciodt=0,15&hl=en",2,"2019-06-10","","","","",,,,,366,24.40,61,6,15
242,"T Tang, L Li, J Tang, Y Li, WY Lin, F Martin…","A mouse knockout library for secreted and transmembrane proteins",2010,"Nature …","nature.com","https://www.nature.com/nbt/journal/v28/n7/abs/nbt.1644.html","https://scholar.google.com/scholar?cites=9939659215143453249&as_sdt=800005&sciodt=0,15&hl=en",3,"2019-06-10","","","","",,,,,242,26.89,35,7,9
237,"HJ Junge, S Yang, JB Burton, K Paes, X Shu…","TSPAN12 regulates retinal vascular development by promoting Norrin-but not Wnt-induced FZD4/β-catenin signaling",2009,"Cell","Elsevier","https://www.sciencedirect.com/science/article/pii/S0092867409010423","https://scholar.google.com/scholar?cites=2021422040362982856&as_sdt=800005&sciodt=0,15&hl=en",4,"2019-06-10","HTML","","","",,,,,237,23.70,40,6,10
196,"W Ye, N Ali, ME Bembenek, SB Shears…","Inhibition of clathrin assembly by high affinity binding of specific inositol polyphosphates to the synapse-specific clathrin assembly protein AP-3",1995,"Journal of Biological …","ASBMB","http://www.jbc.org/content/270/4/1564.short","https://scholar.google.com/scholar?cites=4948752035355201490&as_sdt=800005&sciodt=0,15&hl=en",5,"2019-06-10","","","","",,,,,196,8.17,39,5,24
198,"DM Stone, M Murone, S Luoh, W Ye, MP Armanini…","Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli",1999,"J Cell Sci","jcs.biologists.org","http://jcs.biologists.org/content/112/23/4437.short","https://scholar.google.com/scholar?cites=17393099306329433586&as_sdt=800005&sciodt=0,15&hl=en",6,"2019-06-10","","","","",,,,,198,9.90,33,6,20
196,"M Schmidt, K Paes, A De Mazière, T Smyczek…","EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution",2007,"…","dev.biologists.org","http://dev.biologists.org/content/134/16/2913.short","https://scholar.google.com/scholar?cites=5163033396548517573&as_sdt=800005&sciodt=0,15&hl=en",7,"2019-06-10","","","","",,,,,196,16.33,39,5,12
196,"Z Jiang, S Jhunjhunwala, J Liu, PM Haverty…","The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients",2012,"Genome …","genome.cshlp.org","http://genome.cshlp.org/content/22/4/593.short","https://scholar.google.com/scholar?cites=3887290714520834550&as_sdt=800005&sciodt=0,15&hl=en",8,"2019-06-10","","","","",,,,,196,28.00,39,5,7
162,"M Hynes, W Ye, K Wang, D Stone, M Murone…","The seven-transmembrane receptor smoothened cell-autonomously induces multiple ventral cell types",2000,"Nature …","nature.com","https://www.nature.com/articles/nn0100_41","https://scholar.google.com/scholar?cites=15169677696082428787&as_sdt=800005&sciodt=0,15&hl=en",9,"2019-06-10","","","","",,,,,162,8.53,27,6,19
161,"M van Lookeren Campagne, J LeCouter…","Mechanisms of age‐related macular degeneration and therapeutic opportunities",2014,"The Journal of …","Wiley Online Library","https://onlinelibrary.wiley.com/doi/abs/10.1002/path.4266","https://scholar.google.com/scholar?cites=454595423979842490&as_sdt=800005&sciodt=0,15&hl=en",10,"2019-06-10","","","","",,,,,161,32.20,54,3,5
141,"F Oakley, N Trim, CM Constandinou, W Ye…","Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis",2003,"The American journal of …","Elsevier","https://www.sciencedirect.com/science/article/pii/S0002944010635444","https://scholar.google.com/scholar?cites=4370452704388155888&as_sdt=800005&sciodt=0,15&hl=en",11,"2019-06-10","HTML","","","",,,,,141,8.81,28,5,16
144,"SE Craven, KC Lim, W Ye, JD Engel…","Gata2 specifies serotonergic neurons downstream of sonic hedgehog",2004,"…","dev.biologists.org","http://dev.biologists.org/content/131/5/1165.short","https://scholar.google.com/scholar?cites=5904685709248837584&as_sdt=800005&sciodt=0,15&hl=en",12,"2019-06-10","","","","",,,,,144,9.60,29,5,15
131,"W Ye, M Bouchard, D Stone, X Liu, F Vella, J Lee…","Distinct regulators control the expression of the mid-hindbrain organizer signal FGF8",2001,"Nature …","nature.com","https://www.nature.com/articles/nn761","https://scholar.google.com/scholar?cites=9721940922523875389&as_sdt=800005&sciodt=0,15&hl=en",13,"2019-06-10","","","","",,,,,131,7.28,19,7,18
110,"SE Craven, D French, W Ye, F de Sauvage…","Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome",2005,"Blood","Am Soc Hematology","http://www.bloodjournal.org/content/105/9/3528.short","https://scholar.google.com/scholar?cites=10451298970476264844&as_sdt=800005&sciodt=0,15&hl=en",14,"2019-06-10","","","","",,,,,110,7.86,22,5,14
81,"M Evangelista, TY Lim, J Lee, L Parker, A Ashique…","Kinome siRNA screen identifies regulators of ciliogenesis and hedgehog signal transduction",2008,"Sci. Signal …","stke.sciencemag.org","http://stke.sciencemag.org/content/1/39/ra7.full-text.pdf+html","https://scholar.google.com/scholar?cites=12275122177704072731&as_sdt=800005&sciodt=0,15&hl=en",15,"2019-06-10","","","","",,,,,81,7.36,14,6,11
75,"W Ye, EM Lafer","Clathrin binding and assembly activities of expressed domains of the synapse-specific clathrin assembly protein AP-3",1995,"Journal of Biological Chemistry","ASBMB","http://www.jbc.org/content/270/18/10933.short","https://scholar.google.com/scholar?cites=16362936379609343965&as_sdt=800005&sciodt=0,15&hl=en",16,"2019-06-10","","","","",,,,,75,3.13,38,2,24
67,"Y Wu, W Ye, JB Burton, C Chiu","Method of treating retinopathy with an anti-LRP5 antibody",2018,"US Patent App. 10/035,854","Google Patents","https://patents.google.com/patent/US10035854B2/en","https://scholar.google.com/scholar?cites=13265355382298440849&as_sdt=800005&sciodt=0,15&hl=en",17,"2019-06-10","","","","",,,,,67,67.00,17,4,1
64,"C Campa, I Kasman, W Ye, WP Lee…","Effects of an anti–VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes",2008,"… & visual science","iovs.arvojournals.org","https://iovs.arvojournals.org/article.aspx?articleid=2184636","https://scholar.google.com/scholar?cites=5199364484543099276&as_sdt=800005&sciodt=0,15&hl=en",18,"2019-06-10","HTML","","","",,,,,64,5.82,13,5,11
62,"CS Aung, W Ye, G Plowman, AA Peters…","Plasma membrane calcium ATPase 4 and the remodeling of calcium homeostasis in human colon cancer cells",2009,"…","academic.oup.com","https://academic.oup.com/carcin/article-abstract/30/11/1962/2629507","https://scholar.google.com/scholar?cites=13771160480342250669&as_sdt=800005&sciodt=0,15&hl=en",19,"2019-06-10","","","","",,,,,62,6.20,12,5,10
55,"P Vitorino, S Yeung, A Crow, J Bakke, T Smyczek…","MAP4K4 regulates integrin-FERM binding to control endothelial cell motility",2015,"Nature","nature.com","https://www.nature.com/articles/nature14323","https://scholar.google.com/scholar?cites=1960266784038225567&as_sdt=800005&sciodt=0,15&hl=en",20,"2019-06-10","","","","",,,,,55,13.75,9,6,4
49,"A De Mazière, L Parker, S Van Dijk…","Egfl7 knockdown causes defects in the extension and junctional arrangements of endothelial cells during zebrafish vasculogenesis",2008,"… dynamics: an official …","Wiley Online Library","https://onlinelibrary.wiley.com/doi/abs/10.1002/dvdy.21441","https://scholar.google.com/scholar?cites=16303453852408798723&as_sdt=800005&sciodt=0,15&hl=en",21,"2019-06-10","","","","",,,,,49,4.45,12,4,11
49,"W Ye","The complexity of translating anti-angiogenesis therapy from basic science to the clinic",2016,"Developmental cell","Elsevier","https://www.sciencedirect.com/science/article/pii/S1534580716301605","https://scholar.google.com/scholar?cites=12582785532069075596&as_sdt=800005&sciodt=0,15&hl=en",22,"2019-06-10","HTML","","","",,,,,49,16.33,49,1,3
50,"A Gogineni, M Caunt, A Crow, CV Lee, G Fuh…","Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis",2013,"PloS one","journals.plos.org","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0068755","https://scholar.google.com/scholar?cites=12701223844590240663&as_sdt=800005&sciodt=0,15&hl=en",23,"2019-06-10","HTML","","","",,,,,50,8.33,8,6,6
42,"CW Wilson, LH Parker, CJ Hall, T Smyczek, J Mak…","Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signaling",2013,"Blood","Am Soc Hematology","http://www.bloodjournal.org/content/122/22/3678.short","https://scholar.google.com/scholar?cites=8352200099242852902&as_sdt=800005&sciodt=0,15&hl=en",24,"2019-06-10","","","","",,,,,42,7.00,7,6,6
38,"A Rosenthal, MA Hynes, W Ye","Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells",2001,"US Patent 6,277,820","Google Patents","https://patents.google.com/patent/US6277820B1/en","https://scholar.google.com/scholar?cites=9077106082250957947&as_sdt=800005&sciodt=0,15&hl=en",25,"2019-06-10","","","","",,,,,38,2.11,13,3,18
33,"K Baker, N Ferrara, H Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2003,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20030100497A1/en","https://scholar.google.com/scholar?cites=13416271479817858887&as_sdt=800005&sciodt=0,15&hl=en",26,"2019-06-10","","","","",,,,,33,2.06,7,5,16
30,"M Schmidt, A De Mazière, T Smyczek…","The role of Egfl7 in vascular morphogenesis",2007,"Novartis Foundation …","books.google.com","https://books.google.com/books?hl=en&lr=&id=FqRX7A8UrVUC&oi=fnd&pg=PA18&dq=%22weilan+ye%22&ots=1afnWarP5_&sig=swNFrgCH6Ai1VQHQJl_hGaYs56k","https://scholar.google.com/scholar?cites=5319530628167437697&as_sdt=800005&sciodt=0,15&hl=en",27,"2019-06-10","","","","",,,,,30,2.50,8,4,12
30,"TD Crawford, CO Ndubaku, H Chen…","Discovery of selective 4-amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization",2014,"Journal of medicinal …","ACS Publications","https://pubs.acs.org/doi/abs/10.1021/jm500155b","https://scholar.google.com/scholar?cites=6255647734857923979&as_sdt=800005&sciodt=0,15&hl=en",28,"2019-06-10","","","","",,,,,30,6.00,8,4,5
27,"D Sampath, J Oeh, SK Wyatt, TC Cao, H Koeppen…","Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular response",2013,"Neoplasia","Elsevier","https://www.sciencedirect.com/science/article/pii/S1476558613800644","https://scholar.google.com/scholar?cites=3744434021502511378&as_sdt=800005&sciodt=0,15&hl=en",29,"2019-06-10","","","","",,,,,27,4.50,5,6,6
24,"L Johnson, M Huseni, T Smyczek…","Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy",2013,"The Journal of …","Am Soc Clin Investig","https://www.jci.org/articles/view/67892","https://scholar.google.com/scholar?cites=1692516892922458274&as_sdt=800005&sciodt=0,15&hl=en",30,"2019-06-10","HTML","","","",,,,,24,4.00,6,4,6
22,"K Baker, N Ferrara, H Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2004,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20040043927A1/en","https://scholar.google.com/scholar?cites=15871121803456634909&as_sdt=800005&sciodt=0,15&hl=en",31,"2019-06-10","","","","",,,,,22,1.47,4,5,15
23,"CW Wilson, W Ye","Regulation of vascular endothelial junction stability and remodeling through Rap1-Rasip1 signaling",2014,"Cell adhesion & migration","Taylor & Francis","https://www.tandfonline.com/doi/abs/10.4161/cam.28115","https://scholar.google.com/scholar?cites=15346923710205270465&as_sdt=800005&sciodt=0,15&hl=en",32,"2019-06-10","","","","",,,,,23,4.60,12,2,5
18,"CO Ndubaku, TD Crawford, H Chen…","Structure-based design of GNE-495, a potent and selective MAP4K4 inhibitor with efficacy in retinal angiogenesis",2015,"ACS medicinal …","ACS Publications","https://pubs.acs.org/doi/abs/10.1021/acsmedchemlett.5b00174","https://scholar.google.com/scholar?cites=537287878180359291&as_sdt=800005&sciodt=0,15&hl=en",33,"2019-06-10","","","","",,,,,18,4.50,5,4,4
16,"K Baker, N Ferrara, H Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2003,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20030125521A1/en","https://scholar.google.com/scholar?cites=3002692206025775777&as_sdt=800005&sciodt=0,15&hl=en",34,"2019-06-10","","","","",,,,,16,1.00,3,5,16
16,"L Wang, M Stanley, JW Boggs, TD Crawford…","Fragment-based identification and optimization of a class of potent pyrrolo [2, 1-f][1, 2, 4] triazine MAP4K4 inhibitors",2014,"Bioorganic & medicinal …","Elsevier","https://www.sciencedirect.com/science/article/pii/S0960894X14007951","https://scholar.google.com/scholar?cites=14659883148226456502&as_sdt=800005&sciodt=0,15&hl=en",35,"2019-06-10","HTML","","","",,,,,16,3.20,3,5,5
16,"K Baker, N Ferrara, H Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2003,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20030119112A1/en","https://scholar.google.com/scholar?cites=12592220647454391125&as_sdt=800005&sciodt=0,15&hl=en",36,"2019-06-10","","","","",,,,,16,1.00,3,5,16
13,"J Brennan, FJ De Sauvage, E Filvaroff…","Novel Gene Disruptions, Composition and Methods Relating Thereto",2008,"US Patent App. 11 …","Google Patents","https://patents.google.com/patent/US20080305106A1/en","https://scholar.google.com/scholar?cites=6202376451896591379&as_sdt=800005&sciodt=0,15&hl=en",37,"2019-06-10","","","","",,,,,13,1.18,3,4,11
12,"HJ Junge, W Ye","Methods for inhibiting ocular angiogenesis",2010,"US Patent App. 12/557,394","Google Patents","https://patents.google.com/patent/US20100129375A1/en","https://scholar.google.com/scholar?cites=9721303563449148278&as_sdt=800005&sciodt=0,15&hl=en",38,"2019-06-10","","","","",,,,,12,1.33,6,2,9
11,"WC Liang, GD Plowman, Y Wu, W Ye","Antibodies",2011,"US Patent 7,973,138","Google Patents","https://patents.google.com/patent/US7973138B2/en","https://scholar.google.com/scholar?cites=4108245381026807321&as_sdt=800005&sciodt=0,15&hl=en",39,"2019-06-10","","","","",,,,,11,1.38,3,4,8
11,"A Chuntharapai, GD Plowman…","Combinatorial therapy",2009,"US Patent App. 12 …","Google Patents","https://patents.google.com/patent/US20090220504A1/en","https://scholar.google.com/scholar?cites=2153795172883397448&as_sdt=800005&sciodt=0,15&hl=en",40,"2019-06-10","","","","",,,,,11,1.10,4,3,10
10,"E Filvaroff, W Ye, L Parker, JA Hongo…","Compositions and methods for modulating vascular development",2007,"US Patent App. 11 …","Google Patents","https://patents.google.com/patent/US20070031437A1/en","https://scholar.google.com/scholar?cites=4307012899261798817&as_sdt=800005&sciodt=0,15&hl=en",41,"2019-06-10","","","","",,,,,10,0.83,2,5,12
10,"R García‐Carbonero, E van Cutsem, F Rivera…","Randomized phase II trial of parsatuzumab (anti‐EGFL7) or placebo in combination with FOLFOX and bevacizumab for first‐line metastatic colorectal cancer",2017,"The …","AlphaMed Press","http://theoncologist.alphamedpress.org/content/22/4/375.short","https://scholar.google.com/scholar?cites=17064151301613394712&as_sdt=800005&sciodt=0,15&hl=en",42,"2019-06-10","","","","",,,,,10,5.00,3,4,2
10,"AAB Horner, CB Clarke, KE Combs…","Novel Gene Disruptions, Compostitions and Methods Relating Thereto",2011,"US Patent App. 11 …","Google Patents","https://patents.google.com/patent/US20110097330A1/en","https://scholar.google.com/scholar?cites=1322857360085947695&as_sdt=800005&sciodt=0,15&hl=en",43,"2019-06-10","","","","",,,,,10,1.25,3,4,8
10,"W Ye, MS Dennis, J Fredrickson","Humanized anti-EGFL7 antibodies and methods using same",2013,"US Patent 8,574,576","Google Patents","https://patents.google.com/patent/US8574576B2/en","https://scholar.google.com/scholar?cites=3673096003619696865&as_sdt=800005&sciodt=0,15&hl=en",44,"2019-06-10","","","","",,,,,10,1.67,3,3,6
6,"YYTMQ Weilan, DYS Ke","Study on mechanism of treatment dyestuff wastewater by the dynamic intensified micro-electrolysis device [J]",2004,"Techniques and Equipment for …","en.cnki.com.cn","http://en.cnki.com.cn/Article_en/CJFDTOTAL-HJJZ200406006.htm","https://scholar.google.com/scholar?cites=5976110392218794697&as_sdt=800005&sciodt=0,15&hl=en",45,"2019-06-10","","","","",,,,,6,0.40,3,2,15
6,"K Baker, N Ferrara, HP Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2003,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20030224984A1/en","https://scholar.google.com/scholar?cites=15623842025009392454&as_sdt=800005&sciodt=0,15&hl=en",46,"2019-06-10","","","","",,,,,6,0.38,1,5,16
6,"K Baker, N Ferrara, H Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2003,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20030186866A1/en","https://scholar.google.com/scholar?cites=4911973160903827926&as_sdt=800005&sciodt=0,15&hl=en",47,"2019-06-10","","","","",,,,,6,0.38,1,5,16
5,"W Ye, M Schmidt, JA Hongo, Y Wu","Antibodies to EGFL7 and methods for their use",2013,"US Patent 8,398,976","Google Patents","https://patents.google.com/patent/US8398976B2/en","https://scholar.google.com/scholar?cites=20062542471114440&as_sdt=800005&sciodt=0,15&hl=en",48,"2019-06-10","","","","",,,,,5,0.83,1,4,6
4,"E Filvaroff, W Ye, LH Parker IV, JAS Hongo…","Compositions and methods for modulating vascular development",2009,"US Patent App. 12 …","Google Patents","https://patents.google.com/patent/US20090297512A1/en","https://scholar.google.com/scholar?cites=11042656025668382937&as_sdt=800005&sciodt=0,15&hl=en",49,"2019-06-10","","","","",,,,,4,0.40,1,5,10
4,"A Chuntharapai, GD Plowman…","Anti-alpha5/beta1 antibody",2013,"US Patent …","Google Patents","https://patents.google.com/patent/US8350010B2/en","https://scholar.google.com/scholar?cites=18106717690005915803&as_sdt=800005&sciodt=0,15&hl=en",50,"2019-06-10","","","","",,,,,4,0.67,1,3,6
4,"J von Pawel, DR Spigel, T Ervin, G Losonczy…","Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non …",2018,"The …","AlphaMed Press","http://theoncologist.alphamedpress.org/content/23/6/654.short","https://scholar.google.com/scholar?cites=17834395926145122937&as_sdt=800005&sciodt=0,15&hl=en",51,"2019-06-10","","","","",,,,,4,4.00,1,5,1
4,"K Baker, N Ferrara, H Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2003,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20030105012A1/en","https://scholar.google.com/scholar?cites=9264801853092537988&as_sdt=800005&sciodt=0,15&hl=en",52,"2019-06-10","","","","",,,,,4,0.25,1,5,16
3,"W Ye, M Schmidt, JA Hongo, Y Wu","Antibodies to egfl7 and methods for their use",2010,"US Patent App. 12/280,673","Google Patents","https://patents.google.com/patent/US20100203041A1/en","https://scholar.google.com/scholar?cites=18044771990648812224&as_sdt=800005&sciodt=0,15&hl=en",53,"2019-06-10","","","","",,,,,3,0.33,1,4,9
3,"WC Liang, GD Plowman, Y Wu, W Ye","Novel antibodies",2009,"US Patent App. 12/237,640","Google Patents","https://patents.google.com/patent/US20090098112A1/en","https://scholar.google.com/scholar?cites=1053273571142013849&as_sdt=800005&sciodt=0,15&hl=en",54,"2019-06-10","","","","",,,,,3,0.30,1,4,10
3,"KP Baker, N Ferrara, H Gerber, ME Gerritsen…","PRO20044 nucleic acids",2006,"US Patent …","Google Patents","https://patents.google.com/patent/US7135334B2/en","https://scholar.google.com/scholar?cites=7244713377547923630&as_sdt=800005&sciodt=0,15&hl=en",55,"2019-06-10","","","","",,,,,3,0.23,1,5,13
2,"S Yeung, T Smyczek, J Cheng, A Lima, R Molina…","Inhibiting vascular morphogenesis in tumors: Egfl7 as a novel therapeutic target",2011,"","AACR","http://cancerres.aacrjournals.org/content/71/8_Supplement/3295.short","https://scholar.google.com/scholar?cites=13198584375187565680&as_sdt=800005&sciodt=0,15&hl=en",56,"2019-06-10","","","","",,,,,2,0.25,0,6,8
3,"ND Stanković, F Bicker, S Keller…","EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors",2018,"EMBO molecular …","embomolmed.embopress.org","http://embomolmed.embopress.org/content/10/9/e8420.abstract","https://scholar.google.com/scholar?cites=7321066321115050460&as_sdt=800005&sciodt=0,15&hl=en",57,"2019-06-10","","","","",,,,,3,3.00,1,4,1
2,"K Baker, N Ferrara, H Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2003,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20030105011A1/en","https://scholar.google.com/scholar?cites=4921466637685208599&as_sdt=800005&sciodt=0,15&hl=en",58,"2019-06-10","","","","",,,,,2,0.13,0,5,16
1,"WC Liang, GD Plowman, Y Wu, W Ye","Anti-α5β1 antibodies and uses thereof",2015,"US Patent 8,962,275","Google Patents","https://patents.google.com/patent/US8962275B2/en","https://scholar.google.com/scholar?cites=3559683743342611782&as_sdt=800005&sciodt=0,15&hl=en",59,"2019-06-10","","","","",,,,,1,0.25,0,4,4
1,"K Baker, N Ferrara, H Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2003,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20030105013A1/en","https://scholar.google.com/scholar?cites=3073337882254523491&as_sdt=800005&sciodt=0,15&hl=en",60,"2019-06-10","","","","",,,,,1,0.06,0,5,16
1,"W Ye, M Dennis, J Fredrickson","Humanized anti-EGFL7 antibodies and methods using same",2013,"US Patent 8,404,811","Google Patents","https://patents.google.com/patent/US8404811B2/en","https://scholar.google.com/scholar?cites=1463961349893804985&as_sdt=800005&sciodt=0,15&hl=en",61,"2019-06-10","","","","",,,,,1,0.17,0,3,6
1,"WC Liang, GD Plowman, Y Wu, W Ye","Novel antibodies",2012,"US Patent App. 13/112,839","Google Patents","https://patents.google.com/patent/US20120156129A1/en","https://scholar.google.com/scholar?cites=16675409291482442301&as_sdt=800005&sciodt=0,15&hl=en",62,"2019-06-10","","","","",,,,,1,0.14,0,4,7
1,"WC Liang, GD Plowman, Y Wu, W Ye","Antibodies",2014,"US Patent 8,840,887","Google Patents","https://patents.google.com/patent/US8840887B2/en","https://scholar.google.com/scholar?cites=1319800137856115172&as_sdt=800005&sciodt=0,15&hl=en",63,"2019-06-10","","","","",,,,,1,0.20,0,4,5
1,"WC Liang, GD Plowman, Y Wu, W Ye","Anti-α5 β1 antibodies and uses thereof",2012,"US Patent 8,124,740","Google Patents","https://patents.google.com/patent/US8124740B2/en","https://scholar.google.com/scholar?cites=7665869503382975465&as_sdt=800005&sciodt=0,15&hl=en",64,"2019-06-10","","","","",,,,,1,0.14,0,4,7
1,"F De Sauvage, D French, L Gonzalez…","Novel gene disruptions, compositions and methods relating thereto",2012,"US Patent App. 13 …","Google Patents","https://patents.google.com/patent/US20120210450A1/en","https://scholar.google.com/scholar?cites=11999976754833720687&as_sdt=800005&sciodt=0,15&hl=en",65,"2019-06-10","","","","",,,,,1,0.14,0,4,7
1,"CD Weekes, LS Rosen, A Capasso, KM Wong…","Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors",2018,"Cancer chemotherapy …","Springer","https://link.springer.com/article/10.1007/s00280-018-3622-8","https://scholar.google.com/scholar?cites=12145832805588629149&as_sdt=800005&sciodt=0,15&hl=en",66,"2019-06-10","HTML","","","",,,,,1,1.00,0,5,1
1,"A Chuntharapai, GD Plowman…","Combinatorial therapy",2014,"US Patent App. 13 …","Google Patents","https://patents.google.com/patent/US20140004038A1/en","https://scholar.google.com/scholar?cites=2250432823928109043&as_sdt=800005&sciodt=0,15&hl=en",67,"2019-06-10","","","","",,,,,1,0.20,0,3,5
1,"KE Combs, LL Culbertson, F De Sauvage…","Novel gene disruptions, compositions and methods relating thereto",2012,"US Patent App. 12 …","Google Patents","https://patents.google.com/patent/US20120030776A1/en","https://scholar.google.com/scholar?cites=9736185767264297291&as_sdt=800005&sciodt=0,15&hl=en",68,"2019-06-10","","","","",,,,,1,0.14,0,4,7
1,"Y Wu, W Ye, JB Burton, C Chiu","Anti-LRP5 antibodies and methods of use",2016,"US Patent 9,522,954","Google Patents","https://patents.google.com/patent/US9522954B2/en","https://scholar.google.com/scholar?cites=8159682390361581880&as_sdt=800005&sciodt=0,15&hl=en",69,"2019-06-10","","","","",,,,,1,0.33,0,4,3
0,"A Goddard, W Wood, W Ye, Z Zhang","Novel secreted polypeptide and methods of treatment of bone disorders",2005,"US Patent App. 10/934,892","Google Patents","https://patents.google.com/patent/US20050037465A1/en","",70,"2019-06-10","","","","",,,,,0,0.00,0,4,14
0,"A Goddard, W Wood, W Ye, Z Zhang","Novel secreted polypeptide and methods of treatment of bone disorders",2003,"US Patent App. 10/020,419","Google Patents","https://patents.google.com/patent/US20030044897A1/en","",71,"2019-06-10","","","","",,,,,0,0.00,0,4,16
0,"M Schmidt, T Smyczek, W Ye","Role of EGFL7 during blood vessel formation and remodelling",2006,"Vascular Pharmacology","infona.pl","https://www.infona.pl/resource/bwmeta1.element.elsevier-f5fe86ab-3fd1-3b6f-9c8f-e9d2b80b4ff9","",72,"2019-06-10","CITATION","","","",,,,,0,0.00,0,3,13
0,"HJ Junge, W Ye","Methods for inhibiting ocular angiogenesis",2015,"US Patent App. 14/262,368","Google Patents","https://patents.google.com/patent/US20150093375A1/en","",73,"2019-06-10","","","","",,,,,0,0.00,0,2,4
0,"W Ye, MS Dennis, J Fredrickson","Humanized anti-egfl7 antibodies and methods using same",2014,"US Patent App. 13/668,054","Google Patents","https://patents.google.com/patent/US20140051120A1/en","",74,"2019-06-10","","","","",,,,,0,0.00,0,3,5
0,"M Huseni, E Kadel, R Desai, D Kan, J Cheng, SF Yu…","Abstract B205: Evaluation of circulating CD34+ cells following treatment with anti‐EGFL7 in preclinical models of efficacy",2009,"","AACR","http://mct.aacrjournals.org/content/8/12_Supplement/B205.short","",75,"2019-06-10","","","","",,,,,0,0.00,0,7,10
0,"Y Wu, W Ye, JB Burton, C Chiu","Anti-LRP5 antibodies and methods of use",2015,"US Patent 9,200,072","Google Patents","https://patents.google.com/patent/US9200072B2/en","",76,"2019-06-10","","","","",,,,,0,0.00,0,4,4
0,"W Ye, M Schmidt, JA Hongo, Y Wu","Antibodies to egfl7 and methods for their use",2013,"US Patent App. 13/755,950","Google Patents","https://patents.google.com/patent/US20130129735A1/en","",77,"2019-06-10","","","","",,,,,0,0.00,0,4,6
0,"W Ye, MS Dennis, J Fredrickson","Humanized anti-egfl7 antibodies and methods using same",2013,"US Patent App. 13/944,538","Google Patents","https://patents.google.com/patent/US20130324704A1/en","",78,"2019-06-10","","","","",,,,,0,0.00,0,3,6
0,"M Huseni, L Rosen, M Gordon, P Munster, T Smyczek…","Preclinical and clinical evaluation of pharmacodynamic biomarkers of a novel anti-angiogenesis agent, anti-EGFL7",2011,"","AACR","http://cancerres.aacrjournals.org/content/71/8_Supplement/3284.short","",79,"2019-06-10","","","","",,,,,0,0.00,0,6,8
0,"W Ye, LH Parker IV, CW Wilson","Treatment of disorders with altered vascular barrier function",2014,"US Patent App. 14/022,475","Google Patents","https://patents.google.com/patent/US20140005113A1/en","",80,"2019-06-10","","","","",,,,,0,0.00,0,3,5
0,"DM Stone, M Murone, SM Luoh…","CA 94080, USA'Author for correspondence (e-mail: ar© gene. com) Accepted 22 September: published on WWW 17 November 1999",1999,"Journal of Cell …","Cambridge University Press","","",81,"2019-06-10","CITATION","","","",,,,,0,0.00,0,4,20
0,"W Ye, LH Parker, CW Wilson","Treatment of disorders with altered vascular barrier function",2015,"US Patent App. 14/604,556","Google Patents","https://patents.google.com/patent/US20150366930A1/en","",82,"2019-06-10","","","","",,,,,0,0.00,0,3,4
0,"M Merchant, W Ye, F de Sauvage","Hedgehog Signaling and Embryonic Development",2003,"Handbook of Cell Signaling","Elsevier","","",83,"2019-06-10","CITATION","","","",,,,,0,0.00,0,3,16
0,"W Ye, MS Dennis, J Fredrickson","Humanized anti-egfl7 antibodies and methods using same",2013,"US Patent App. 13/668,028","Google Patents","https://patents.google.com/patent/US20130149307A1/en","",84,"2019-06-10","","","","",,,,,0,0.00,0,3,6
0,"HJ Junge, W Ye","Methods for inhibiting ocular angiogenesis",2012,"US Patent App. 13/218,360","Google Patents","https://patents.google.com/patent/US20120276083A1/en","",85,"2019-06-10","","","","",,,,,0,0.00,0,2,7
0,"M Schmidt, A De Mazière, T Smyczek…","The role of Egﬂ7 in vascular morphogenesis",2007,"Vascular …","Wiley-Interscience","","",86,"2019-06-10","CITATION","","","",,,,,0,0.00,0,4,12
0,"Y Wu, W Ye, JB Burton, C Chiu","Anti-lrp5 antibodies and methods of use",2019,"US Patent App. 16/018,458","Google Patents","https://patents.google.com/patent/US20190010228A1/en","",87,"2019-06-10","","","","",,,,,0,0.00,0,4,1
0,"W Ye, MS Dennis, J Fredrickson","Humanized anti-egfl7 antibodies and methods using same",2013,"US Patent App. 13/668,086","Google Patents","https://patents.google.com/patent/US20130129749A1/en","",88,"2019-06-10","","","","",,,,,0,0.00,0,3,6
0,"Y Wu, W Ye, JB Burton, C Chiu","Anti-lrp5 antibodies and methods of use",2017,"US Patent App. 15/349,757","Google Patents","https://patents.google.com/patent/US20170166636A1/en","",89,"2019-06-10","","","","",,,,,0,0.00,0,4,2
0,"WC Liang, GD Plowman, Y Wu, W Ye","Novel anti-alpha5 beta1 antibodies and uses thereof",2015,"US Patent App. 14/593,950","Google Patents","https://patents.google.com/patent/US20150203581A1/en","",90,"2019-06-10","","","","",,,,,0,0.00,0,4,4
0,"F Peale, L Sanders, R Yu, S Chan, R Raja, R Patel…","Abstract LB-312: Egfl7 is expressed in a broad range of human tumors with apparent restriction to the endothelium",2012,"","AACR","http://cancerres.aacrjournals.org/content/72/8_Supplement/LB-312.short","",91,"2019-06-10","","","","",,,,,0,0.00,0,7,7
0,"K Baker, N Ferrara, H Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2003,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20030109438A1/en","",92,"2019-06-10","","","","",,,,,0,0.00,0,5,16
0,"E Filvaroff, W Ye, LH Parker IV, JAS Hongo…","Compositions and methods for modulating vascular development",2014,"US Patent …","Google Patents","https://patents.google.com/patent/US8790646B2/en","",93,"2019-06-10","","","","",,,,,0,0.00,0,5,5
0,"W Ye","SERPINs shelter the endowed migrants in a hostile land",2014,"The EMBO journal","emboj.embopress.org","http://emboj.embopress.org/content/33/8/786.abstract","",94,"2019-06-10","","","","",,,,,0,0.00,0,1,5
0,"M Schmidt, S Ross, L Crocker, F Peale, R Watts, W Ye","Vascular changes in mouse tumors following endothelial cell targeted therapy",2006,"","fasebj.org","https://www.fasebj.org/doi/abs/10.1096/fasebj.20.5.A1100-b","",95,"2019-06-10","","","","",,,,,0,0.00,0,6,13
0,"W Mallet, Y Chen, G Frantz, H Koeppen, L Parker…","The candidate guidance molecule, Semaphorin 5B, is over-expressed in kidney cancers",2005,"","AACR","http://cancerres.aacrjournals.org/content/65/9_Supplement/357.2.short","",96,"2019-06-10","","","","",,,,,0,0.00,0,6,14
0,"EE Kadel, M Huseni, D Kan, R Desai, SF Yu, R Raja…","A quantitative real-time RT-PCR gene signature to detect circulating CD34+ cells as a pharmacodynamic biomarker following anti-EGFL7 treatment in preclinical …",2010,"","AACR","http://cancerres.aacrjournals.org/content/70/8_Supplement/1669.short","",97,"2019-06-10","","","","",,,,,0,0.00,0,7,9
0,"WC Liang, GD Plowman, Y Wu, W Ye","Antibodies",2016,"US Patent 9,284,376","Google Patents","https://patents.google.com/patent/US9284376B2/en","",98,"2019-06-10","","","","",,,,,0,0.00,0,4,3
0,"K Baker, N Ferrara, H Gerber, M Gerritsen…","Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis",2003,"US Patent App. 10 …","Google Patents","https://patents.google.com/patent/US20030191059A1/en","",99,"2019-06-10","","","","",,,,,0,0.00,0,5,16
0,"WC Liang, GD Plowman, Y Wu, W Ye","Novel antibodies",2012,"US Patent App. 13/112,833","Google Patents","https://patents.google.com/patent/US20120148572A1/en","",100,"2019-06-10","","","","",,,,,0,0.00,0,4,7
0,"W Ye, MS Dennis, J Fredrickson","Humanized anti-egfl7 antibodies and methods using same",2013,"US Patent App. 13/919,629","Google Patents","https://patents.google.com/patent/US20130287779A1/en","",101,"2019-06-10","","","","",,,,,0,0.00,0,3,6
0,"W Ye, MS Dennis, J Fredrickson","Humanized anti-egfl7 antibodies and methods using same",2013,"US Patent App. 13/668,064","Google Patents","https://patents.google.com/patent/US20130129733A1/en","",102,"2019-06-10","","","","",,,,,0,0.00,0,3,6
0,"W Ye, H Lu","Methods for inhibiting angiogenesis using EGFL8 antagonists",2017,"US Patent 9,549,971","Google Patents","https://patents.google.com/patent/US9549971B2/en","",103,"2019-06-10","","","","",,,,,0,0.00,0,2,2
